Secaucus
-
Quest Expands in Cancer Testing With $300M Haystack Oncology Acquisition
Quest Diagnostics is acquiring liquid biopsy company Haystack Oncology. The startup’s technology is used for identifying cancer patients who need adjuvant therapy.
-
Quest Diagnostics to start coronavirus testing Monday
The lab testing company made the announcement as the virus has rapidly spread across the world, and the administration’s response has received widespread criticism. LabCorp also announced the availability of its test.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Quest Diagnostics acquires Blueprint Genetics
The companies said the deal, financial terms of which were not disclosed, would enable expansion of next-generation sequencing capabilities in rare diseases.
Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
